MedTrace Logo

Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma

NCT00901836 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-02-10

No results posted yet for this study

Summary

The goal of this study is to evaluate radiation treatment intended to increase the chance of curing your sarcoma and decrease the side effects of proton therapy.

This study will also look at the tumor tissue that was removed during your initial biopsy and your final surgery for information that may help to treat retroperitoneal sarcoma in the future.

Conditions

  • Retroperitoneal Sarcoma

Interventions

RADIATION

Preoperative proton therapy

28 daily fractions of 1.8 cobalt gray equivalent(CGE)/fx for total of 50.4 CGE over 5.5 weeks.

PROCEDURE

Surgery

Standard of care surgery will be performed 4-6 weeks after completion of radiation.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Daniel J Indelicato, MD · University of Florida Proton Therapy Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00901836 on ClinicalTrials.gov